Nathaniel R West

9PUBLICATIONS

94CO-AUTHORS

Molecular targetsTumour immunologyChemical and thermal processes in energy and combustionMedical bacteriologyInnate immunity

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|May 06, 2026

Loss of the autoimmune risk gene TREX1 reveals a convergence of mechanisms promoting immune tolerance loss and antitumor immunity.

|Jan 08, 2026

CDK10 inhibits innate sensing to constrain antitumor immunity.

Natalie S Firmino, Nathaniel R West

|Jan 07, 2026

Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosis.

Rojo A Ratsimandresy, Emma Doran, Hart S Dengler

|Feb 05, 2025

IL-27 elicits a cytotoxic CD8<sup>+</sup> T cell program to enforce tumour control.

Béatrice Bréart, Katherine Williams, Stellanie Krimm

|Mar 15, 2024

The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity.

Junghyun Lim, Ryan Rodriguez, Katherine Williams

|Sep 23, 2023

Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer.

Lucia Taraborrelli, Yasin Şenbabaoğlu, Lifen Wang

Pageof 2

Frequent Collaborators

Sören Müller

Katherine Williams

Jack Bevers

Reynold A Panettieri

Sarah E Headland

Jason Vander Heiden

Rajbharan Yadav

Riccardo Guidi

Katrina B Morshead

Jianyong Wang

Frequent Collaborators

Sören Müller

Katherine Williams

Jack Bevers

Reynold A Panettieri